Matthew Januszek brings Ugo Amobi to the Escape Your Limits podcast for one of the program's most forward-looking conversations: an exploration of C60, a carbon molecule discovered through space research that Amobi and his team at Nano Genesis Labs are working to apply to human health. The episode title — Discovering the C60 Miracle Molecule — frames the subject with the same openness the podcast brings to any emerging science: here is something worth examining, here is the person closest to it.
Amobi is not a wellness influencer; he is a founder, chairman, and CEO running a four-year-old bionanotechnology company with a team of engineers and scientists. The conversation covers his company's research into using nanotechnology to deliver natural carbon molecules for purposes ranging from tackling inflammation and chronic pain to improving brain function — and, separately, his work using microgrid technology to electrify the African continent. It is a wide-ranging discussion that rewards listeners willing to follow the science.
About Ugo Amobi
Ugo Amobi leads Nano Genesis Labs, a bionanotechnology company he founded as one of the early commercial ventures exploring the applied science of nanotechnology for human health outcomes. Working alongside engineers and scientists, Amobi's focus is on developing methods to administer natural carbon molecules — most notably C60 — in ways that can address what he describes as some of the world's most significant health challenges: inflammation, chronic pain, cancer, suppressed immunity, and impaired brain function.
The C60 molecule at the center of Nano Genesis Labs' research has an origin story that reaches into space: its discovery during an investigation of carbon molecules in the cosmos later became the foundation for a Nobel Prize, and Amobi argues that its properties make it uniquely suited to a new generation of health applications. His company is developing delivery mechanisms — including vaping as an application method for improving lung function and a C60 supplement combined with ATP and glutathione for energy and focus — that he believes represent a genuine alternative to pharmaceutical approaches for pain management.
Beyond health technology, Amobi has invested in microgrid and energy creation technologies aimed at electrifying Africa's 1.2 billion citizens — a project he frames as the same kind of systems-level problem-solving that drives his nanotechnology work. Both ventures reflect a founder who operates at unusual scale and ambition.
What Ugo Amobi and Matthew Januszek Talked About
- Amobi traces the origin of the C60 molecule to discoveries made during research into carbon molecules in space, connecting a Nobel Prize-winning finding to the current wave of commercial nanotechnology applications he is building.
- He describes Nano Genesis Labs' core mission as using nanotechnology to administer natural carbon molecules with what he characterizes as healing qualities — targeting inflammation, chronic pain, cancer, suppressed immunity, and brain function impairment.
- The episode discusses a C60 supplement formulated with ATP and glutathione, which Amobi says his company developed to support energy, focus, and recovery — positioning it as distinct from conventional supplement approaches.
- Vaping as an administration method receives dedicated discussion: Amobi explains how his company is exploring this application specifically to deliver C60 into the lungs, arguing that the mechanism can be repurposed for therapeutic rather than recreational purposes.
- The conversation addresses the pain management market directly, with Amobi presenting nanotechnology-based solutions as a potential natural alternative to opioid use — a significant claim he grounds in the case studies his team has accumulated.
- Nootropics — compounds Amobi describes as mind expanders — enter the discussion in the context of their potential impact on recovery, sleep, and pain management, with Amobi linking them to the broader suite of applications Nano Genesis Labs is developing.
- The episode covers the effectiveness of glutathione injections versus oral application, illustrating the level of biochemical specificity Amobi brings to his claims about delivery mechanisms and bioavailability.
- Amobi closes by connecting his energy work in Africa to the same underlying philosophy — that access to foundational resources, whether electricity or cell-level health, is a prerequisite for human potential — a framing that resonates directly with the Escape Your Limits brand.
Why This Conversation Matters
The fitness and wellness industry has always sat at the edge of emerging science, and Matthew Januszek's willingness to have conversations like this one with Ugo Amobi reflects his belief that the leaders who build the next generation of fitness products and services will be the ones paying attention to what is happening in adjacent fields.
Whether C60 and nanotechnology ultimately deliver on the potential Amobi describes is a question that science will answer over time. What this episode provides is a clear-eyed introduction to the thinking behind one of the more ambitious companies in the health technology space — useful context for any fitness professional thinking seriously about where wellness is heading.
▶ Watch the full episode on YouTube
Related Episodes & Interviews
About Matthew Januszek
Matthew Januszek is the co-founder of Escape Fitness, the functional-training equipment brand he built from a UK startup into a global name supplying many of the world’s leading gyms, studios, and hotel fitness spaces. Following the separation of the UK and US businesses, Matthew’s focus today is Escape Fitness USA and the next chapter of the brand in North America. He hosted more than 300 episodes of the Escape Your Limits podcast and now co-hosts the LIFTS Podcast with SweatWorks founder Mohammed Iqbal, covering the business, science, and technology shaping the fitness industry. Explore more interviews and episodes on MatthewJanuszek.com.
About The Author
